Your browser doesn't support javascript.
loading
Irisin protected hemopoietic stem cells and improved outcome of severe bone marrow failure.
Li, Hui; Kong, Dexiao; Zhao, Yi; Liu, Xia; Xiao, Fang; Li, Xiaoyan; Hu, Jianting; Chen, Yingjie; Li, Shengli; Wang, Baozhu; Chen, Yuan; Jiang, Yang; Liu, Xiaoli; Feng, Xiumei; Guo, Yanan; Feng, Xiaoli; Ren, Jing; Wang, Fang; Han, Ying; Donelan, William; Yang, Lijun; Xu, Dawei; Tang, Dongqi; Zheng, Chengyun.
Afiliación
  • Li H; Center for Gene and Immunotherapy, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Kong D; Hematology Department, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Institute of Biotherapy for Hematological Malignancies, Shandong University, Jinan, China; Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong Un
  • Zhao Y; Center for Gene and Immunotherapy, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Liu X; Department of Respiratory Intervention, Qilu Children's Hospital of Shandong University, Jinan, China.
  • Xiao F; Department of Health Care and Geriatrics, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Li X; Hematology Department, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Hu J; Shandong Pharmaceutical Academy, Shandong Provincial Key Laboratory of Chemical Drugs, Jinan, China.
  • Chen Y; Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China.
  • Li S; Department of Hematology of Jining No. 1 People's Hospital, Jining, China.
  • Wang B; Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Chen Y; Central Research Laboratory, The second hospital of Shandong University, Jinan, China.
  • Jiang Y; Hematology Department, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Institute of Biotherapy for Hematological Malignancies, Shandong University, Jinan, China; Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong Un
  • Liu X; Hematology Department, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Institute of Biotherapy for Hematological Malignancies, Shandong University, Jinan, China; Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong Un
  • Feng X; Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, China.
  • Guo Y; Hematology Department, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Feng X; Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China.
  • Ren J; Hematology Department, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Wang F; Institute of Medical Sciences, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Han Y; Institute of Medical Sciences, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Donelan W; Department of Urology, College of Medicine, University of Florida, Gainesville, FL, United States.
  • Yang L; Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
  • Xu D; Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong University, Jinan, China; Department of Medicine, Division of Hematology, Center for Molecular Medicine (CMM) and Bioclinicum, Karolinska Institute, Stockholm, Sweden.
  • Tang D; Center for Gene and Immunotherapy, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Electronic address: tangdq@sdu.edu.cn.
  • Zheng C; Hematology Department, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Institute of Biotherapy for Hematological Malignancies, Shandong University, Jinan, China; Shandong University-Karolinska Institute Collaborative Laboratory for Stem Cell Research, Shandong Un
Biomed Pharmacother ; 169: 115863, 2023 Dec 31.
Article en En | MEDLINE | ID: mdl-37952356
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pancitopenia / Células Madre Hematopoyéticas / Anemia Aplásica Límite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pancitopenia / Células Madre Hematopoyéticas / Anemia Aplásica Límite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: China